Markets

Vivos (VIVK) CEO Michael Korenko Buys $11,420 in Stock

Published on 7/15/2026

#VIVK#InsiderBuying#Markets
Vivos (VIVK) CEO Michael Korenko Buys $11,420 in Stock

AI Summary

Summarized by AI from the source below

Michael Korenko, CEO of Vivos Therapeutics (VIVK), purchased $11,420 worth of company stock. This acquisition underscores Korenko's confidence in the company's future performance. Such insider transactions can influence market perceptions and potentially affect stock price behavior. Investors often monitor insider buying activity as a signal of management's belief in the company's prospects.

Share:
Source: Read original article (opens in new tab)

Get the free market brief

Top stories and analysis, summarized. No spam, unsubscribe anytime.

Related News

SpaceX poised for index fund boost with 911.5M shares unlocked
Markets

SpaceX poised for index fund boost with 911.5M shares unlocked

Aug 29

Central Banks Engage with Tokenized Markets at Jackson Hole Discussion
Central Banks

Central Banks Engage with Tokenized Markets at Jackson Hole Discussion

Aug 29

Everus Construction (ECG) Director Buys 1,000 Shares at $144.95
Markets

Everus Construction (ECG) Director Buys 1,000 Shares at $144.95

Aug 29

Post Oak Group Discusses Private Credit's Role in Financing
Markets

Post Oak Group Discusses Private Credit's Role in Financing

Aug 29